This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Valencia: Una estrategia basada en eventos deportivos
Bofarull, Cristina; Gracia, Ignacio; Gómez, SandalioCase SM-1540Innovation and Change, Leadership and People ManagementCualquiera que hubiese estado en Valencia hace 15 años y volviera a visitarla ahora, no la reconocería. El cambio obrado en la ciudad de Valencia en particular, y en toda la Comunidad Valenciana en general, ha hecho que sea una ciudad irreconocible. De una ciudad que vivía de espaldas al mar, puramente industrial y sin apenas relieve internacional ha pasado a ser la ciudad europea que más ha crecido en los últimos quince años gracias al sector se...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00